Southampton Health Technology Assessments Centre (SHTAC)

Publications

Browse our publications catalogue to learn about our research.

Altering product placement to create a healthier layout in supermarkets: outcomes on store sales, customer purchasing and diet in a prospective matched-controlled cluster study.

Christina Vogel, Sarah Crozier, Daniel J Penn-newman, Kylie Ball, Graham Moon, Joanne Lord, Cyrus Cooper & Janis Baird, 2021, PLoS Medicine, 18(9)

DOI: 10.1371/journal.pmed.1003729

Type: article

Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women

Susanne Renz, Fay Chinnery, Beth Stuart, Laura Day, Ingrid Muller, Irene Soulsby, Jacqui Nuttall, Karen Thomas, Kim Suzanne Thomas, Tracey Sach, Louise Stanton, Matthew J Ridd, Nick Francis, Paul Little, Zina Eminton, Gareth Griffiths, Alison M Layton & Miriam Santer, 2021, BMJ Open, 11(8)

DOI: 10.1136/bmjopen-2021-053876

Type: article

Topical preparations for the treatment of mild to moderate acne vulgaris: systematic review and network meta-analysis

Beth Stuart, Emma Maund, Christopher Wilcox, Kannan Sridharan, Gowri Sivaramakrishnan, Constantinos Regas, David Newell, Irene Soulsby, Kar Fat Tang, Andrew Y. Finlay, Heiner C. Bucher, Paul Little, Alison M. Layton & Miriam Santer, 2021, British Journal of Dermatology, 185(3), 512-525

DOI: 10.1111/bjd.20080

Type: review

Bimekizumab for treating moderate to severe chronic plaque psoriasis

Lorna Hazell, Joanne Lord, Neelam Kalita, David Alexander Scott & Jonathan Shepherd, 2021

Type: report

Faricimab for treating diabetic macular oedema

Geoff Frampton, Neelam Kalita, Karen Pickett, Emma Maund, Marcia Tomie Takahashi, David Alexander Scott & Keith Cooper, 2021

Type: report

Semaglutide for managing overweight and obesity

Keith Cooper, Karen Pickett, Geoff Frampton, Neelam Kalita, David Alexander Scott, Emma Maund & Joanne Lord, 2021

Type: report

Tucatinib with trastuzumab and capecitabine for treating HER2-positive unresectable locally advanced or metastatic breast cancer after 2 or more anti-HER2 therapies - A Single Technology Appraisal

David Alexander Scott, Lorna Hazell, Jill L. Colquitt, Neelam Kalita, Joanne Lord, Emma Loveman & Jonathan Shepherd, 2021

Type: report